Scientists have announced a significant breakthrough in the development of a drug to combat Alzheimer's disease. The drug, ...

This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...

A new drug targeting Tau protein shows promise in preventing its accumulation, potentially leading to more effective ...

The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...

Researchers make promising breakthrough in Alzheimer’s drug development: Lancaster Monday, October 7, 2024, 11:00 Hrs [IST] An international team of researchers led by Lancaster ...

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...

(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...

The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...